GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Anadys Pharmaceuticals, Inc. (ANDS) [hlAlert]

Rating:
Outperform
ANDS
up 255.76 %

Anadys Pharmaceuticals, Inc. (ANDS) rated Outperform with price target $2 by Wedbush

Posted on: Tuesday,  Jul 26, 2011  9:25 AM ET by Wedbush

Wedbush rated Outperform Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) on 07/26/2011, when the stock price was $1.04. Since
then, Anadys Pharmaceuticals, Inc. has gained 255.77% as of 11/23/2011's recent price of $3.70.
If you would have followed this Wedbush 's recommendation on ANDS, you would have gained 255.76% of your investment in 120 days.

Anadys Pharmaceuticals, Inc., is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel small molecule medicines for the treatment of viral diseases and cancer. The Company's programs focus on Toll-Like Receptor-based small molecule product candidates and direct antiviral compounds that inhibit key steps in viral proliferation. The Company has core expertise in medicinal chemistry coupled with structure-based drug design, and is developing compounds for the treatment of hepatitis C infection, hepatitis B infection and cancer.

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/26/2011 9:25 AM Buy
None
1.04 2.00
as of 12/30/2011
1 Week   
1 Month   
3 Months up  306.59 %
1 YTD up  255.76 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy